Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) EPS (Basic) (2023 - 2025)

Historic EPS (Basic) for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to -$0.55.

  • Camp4 Therapeutics' EPS (Basic) rose 9772.63% to -$0.55 in Q3 2025 from the same period last year, while for Sep 2025 it was $63.67, marking a year-over-year increase of 15953.81%. This contributed to the annual value of -$11.04 for FY2024, which is 9115.17% up from last year.
  • Per Camp4 Therapeutics' latest filing, its EPS (Basic) stood at -$0.55 for Q3 2025, which was up 9772.63% from -$0.62 recorded in Q2 2025.
  • Over the past 5 years, Camp4 Therapeutics' EPS (Basic) peaked at -$0.55 during Q3 2025, and registered a low of -$30.18 during Q4 2023.
  • Over the past 3 years, Camp4 Therapeutics' median EPS (Basic) value was -$24.19 (recorded in 2024), while the average stood at -$15.64.
  • In the last 5 years, Camp4 Therapeutics' EPS (Basic) skyrocketed by 1718.59% in 2024 and then soared by 9772.63% in 2025.
  • Quarter analysis of 3 years shows Camp4 Therapeutics' EPS (Basic) stood at -$30.18 in 2023, then surged by 90.62% to -$2.83 in 2024, then skyrocketed by 80.57% to -$0.55 in 2025.
  • Its last three reported values are -$0.55 in Q3 2025, -$0.62 for Q2 2025, and -$0.62 during Q1 2025.